Literature DB >> 17905896

Relatively decreased 11C-methionine uptake within the anaplastic component of a mixed-grade oligodendroglioma.

K Miwa1, J Shinoda, H Yano, T Iwama.   

Abstract

A 56-year-old woman presented with a mixed-grade oligodendroglioma. On 11C-methionine [MET]-positron-emission tomography images, heterogeneous uptake of MET was demonstrated in the mass lesion. The part of the lesion with higher MET uptake was identified as an ordinary oligodendroglioma, whereas the part of the lesion with lower MET uptake was an anaplastic component of oligodendroglioma. With oligodendrogliomas, we should be aware of the possibility that MET uptake decreases paradoxically with an increased anaplastic component of oligodendroglioma cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905896      PMCID: PMC8134255          DOI: 10.3174/ajnr.A0695

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  10 in total

1.  Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine.

Authors:  T Ogawa; A Inugami; J Hatazawa; I Kanno; M Murakami; N Yasui; K Mineura; K Uemura
Journal:  AJNR Am J Neuroradiol       Date:  1996-02       Impact factor: 3.825

2.  Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.

Authors:  B Kaschten; A Stevenaert; B Sadzot; M Deprez; C Degueldre; G Del Fiore; A Luxen; M Reznik
Journal:  J Nucl Med       Date:  1998-05       Impact factor: 10.057

3.  Labelling and metabolism of methionine-methyl-11 C.

Authors:  D Comar; J Cartron; M Maziere; C Marazano
Journal:  Eur J Nucl Med       Date:  1976

4.  Non-invasive grading of oligodendrogliomas: correlation between in vivo metabolic pattern and histopathology.

Authors:  J M Derlon; F Chapon; M H Noël; S Khouri; K Benali; M C Petit-Taboué; J P Houtteville; M H Chajari; G Bouvard
Journal:  Eur J Nucl Med       Date:  2000-07

5.  [11C]L-methionine uptake in gliomas.

Authors:  J M Derlon; C Bourdet; P Bustany; M Chatel; J Theron; F Darcel; A Syrota
Journal:  Neurosurgery       Date:  1989-11       Impact factor: 4.654

6.  Amino acid study of cerebral gliomas using positron emission tomography--analysis of (11C-methyl)-L-methionine uptake index.

Authors:  K Mineura; T Sasajima; Y Suda; M Kowada; F Shishido; K Uemura
Journal:  Neurol Med Chir (Tokyo)       Date:  1990-12       Impact factor: 1.742

7.  Positron emission tomography with injection of methionine as a prognostic factor in glioma.

Authors:  O De Witte; I Goldberg; D Wikler; S Rorive; P Damhaut; M Monclus; I Salmon; J Brotchi; S Goldman
Journal:  J Neurosurg       Date:  2001-11       Impact factor: 5.115

Review 8.  Histological grading of gliomas.

Authors:  C Daumas-Duport
Journal:  Curr Opin Neurol Neurosurg       Date:  1992-12

9.  Cerebral glioma: evaluation with methionine PET.

Authors:  T Ogawa; F Shishido; I Kanno; A Inugami; H Fujita; M Murakami; E Shimosegawa; H Ito; J Hatazawa; T Okudera
Journal:  Radiology       Date:  1993-01       Impact factor: 11.105

10.  Brain tumor protein synthesis and histological grades: a study by positron emission tomography (PET) with C11-L-Methionine.

Authors:  P Bustany; M Chatel; J M Derlon; F Darcel; P Sgouropoulos; F Soussaline; A Syrota
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

  10 in total
  2 in total

1.  Detection of histological anaplasia in gliomas with oligodendroglial components using positron emission tomography with (18)F-FDG and (11)C-methionine: report of two cases.

Authors:  Shigeru Yamaguchi; Hiroyuki Kobayashi; Kenji Hirata; Tohru Shiga; Shinya Tanaka; Junichi Murata; Shunsuke Terasaka
Journal:  J Neurooncol       Date:  2010-06-15       Impact factor: 4.130

2.  Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas.

Authors:  Takeko Nojiri; Tadashi Nariai; Masaru Aoyagi; Michio Senda; Kenji Ishii; Kiichi Ishiwata; Kikuo Ohno
Journal:  J Neurooncol       Date:  2008-12-20       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.